HomeTLX • ASX
add
Telix Pharmaceuticals Ltd
Previous close
$14.88
Day range
$14.70 - $15.01
Year range
$8.20 - $15.01
Market cap
4.93B AUD
Avg Volume
1.33M
P/E ratio
926.09
Dividend yield
-
Primary exchange
ASX
In the news
Financials
Income Statement
Revenue
Net income
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 140.86M | 107.07% |
Operating expense | 76.49M | 66.14% |
Net income | 9.77M | 158.85% |
Net profit margin | 6.93 | 128.41% |
Earnings per share | — | — |
EBITDA | 11.55M | 361.45% |
Effective tax rate | -26.93% | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 123.24M | 5.94% |
Total assets | 398.30M | 55.98% |
Total liabilities | 249.39M | 42.23% |
Total equity | 148.91M | — |
Shares outstanding | 323.96M | — |
Price to book | 32.35 | — |
Return on assets | 6.39% | — |
Return on capital | 15.30% | — |
Cash Flow
Net change in cash
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 9.77M | 158.85% |
Cash from operations | 5.31M | 383.26% |
Cash from investing | -11.30M | -299.21% |
Cash from financing | 2.74M | 44.76% |
Net change in cash | -4.25M | -35.24% |
Free cash flow | 7.85M | 633.94% |
About
Founded
2015
Website
Employees
234